Interim Report 2022

09 舜宇光學科技（集團）有限公司 • 2022 中報 Management Discussion and Analysis 管理層討論與分析 Optical Instruments For the six months ended 30 June 2022, the revenue from the Optical Instruments business segment was approximately RMB201.8 million. This segment accounted for approximately 1.2% of the Group’s total revenue, as compared to approximately 0.9% in the corresponding period of last year. In terms of the microscopes business, the Group’s R&D innovation has also achieved certain breakthroughs. During the period under review, the Group has commenced the mass production of the first 25X flat field multiphoton excitation dedicated objectives for commercial use in China. Both of the near-infrared wide field and multiphoton imaging has obtained outstanding performance in life science research field. It has been recognized by many scientific research institutions and universities for the characteristics of in-depth and high spatial resolution. At the same time, the first global near-infrared region-II microscope in vivo imaging system has also been commenced mass production. The equipment has imaging capabilities from visible light to near-infrared light (400- 1,700nm), representing the industry-leading wide-field microscopic maximum detection depth (1.4mm) and minimum resolution (1um). It was a high-precision inspection equipment for the field of living life sciences. In terms of the intelligent equipment business, the Group has achieved various technological breakthroughs. In the industrial field, the Group has successfully completed the R&D of patterned wafer automated optical inspection equipment during the period under review. The equipment can detect defects such as contamination on the wafer surface, short circuits and disconnection, and is equipped with a high-precision motion platform and an autofocus microscopic imaging system solution to achieve sub-micron defect detection, which is in an industry-leading position in domestic market. In the medical field, the Group has commenced the mass production of chromosome caryotype auto microscopic scanner, which can be applied in prenatal examination, screening and diagnosis, genetic diseases diagnosis, hematologic tumor diagnosis and other fields and has successfully replaced imported equipment. 光學儀器 截至二零二二年六月三十日止六個月，光學儀 器事業的收入約人民幣 201,800,000 元。該事 業佔本集團的總收入約 1.2% ，而在去年同期則 佔約 0.9% 。 在顯微鏡業務方面，本集團的研發創新也取得 了一定程度的突破。於回顧期內，本集團實現 了國內首款商用 25X 無限遠平場長工作距多光 子水鏡的批量生產。近紅外寬場和多光子成像 均在生命科學研究領域取得了很好的效果，特 別是大深度高空間分辨率的特點，獲得了多 家科研機構和高校的認可。與此同時，全球 首款近紅外二區活體顯微影像系統亦實現批 量生產。該設備擁有可見光至近紅外光 (400- 1,700nm) 的成像能力，實現了業內寬場微觀最 大探測深度 (1.4mm) 及最小分辨率 (1um) 的領先 水平，為活體生命科學領域提供了高精度的檢 測設備。 在智能裝備業務方面，本集團也獲得多項技術 突破。在工業領域，本集團於回顧期內成功完 成了圖形化晶圓自動光學檢測設備的研發。該 設備可實現晶圓表面髒污、線路短路及斷路等 缺陷的檢測，並採用高精度運動平台與自動對 焦顯微成像系統方案，實現亞微米級的缺陷檢 測，處於國內領先水平。在醫療領域，染色體 核型自動顯微掃描儀實現量產。該設備可應用 在產前檢查的篩查和診斷、遺傳病診斷、血液 腫瘤診斷等領域，成功實現了進口替代。